• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.

作者信息

Kishore B N, Shetty J N

机构信息

Department of Skin, STD and Leprosy, Fr Muller's Institute of Medical Education & Research, Kankanady, Mangalore.

出版信息

Indian J Lepr. 1995 Jul-Sep;67(3):301-8.

PMID:8576609
Abstract

Sixty multibacillary leprosy patients with an average initial bacteriological index (BI) of 2.5 were followed up after they had completed the WHO--recommended multidrug therapy regularly till attaining bacteriological negativity. The minimum duration of treatment was two years as stipulated by WHO and the maximum duration for reaching negativity was seven years (mean 4.25 years). The minimum time for the attainment of bacteriological negativity was one year and the maximum was 6.75 years (mean 3.75 years). The higher the initial BI the longer was the time taken for the attainment of bacteriological negativity. The average fall of BI per year was 0.67. Dapsone monotherapy received before the commencement of MDT, prednisolone received during therapy and the type of leprosy did not have any effect on the time taken for bacteriological clearance. There was no relapse during the period of observation (mean 2.83 years). The site to attain negativity last was the ear lobe, in 95% of the cases.

摘要

相似文献

1
Bacterial clearance with WHO--recommended multidrug regimen for multibacillary leprosy.
Indian J Lepr. 1995 Jul-Sep;67(3):301-8.
2
Daily multidrug therapy for leprosy; results of a fourteen-year experience.麻风病的每日多药疗法;十四年经验结果
Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44.
3
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.多药联合疗法治疗多菌型麻风的疗效:对34例接受多药联合方案治疗直至皮肤涂片转阴的多菌型麻风患者的长期随访
Lepr Rev. 2003 Jun;74(2):141-7.
4
Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.12个月的世界卫生组织/多药联合治疗麻风病方案与结核分枝杆菌疫苗联合用于多菌型麻风病:136例患者的随访
Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.
5
Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.对采用世界卫生组织/多药联合化疗方案进行为期两年固定疗程治疗的高细菌指数多菌型麻风病患者进行长期随访。
Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):405-9.
6
Three years assessment of multidrug therapy in multibacillary leprosy cases.多菌型麻风病例多药联合治疗的三年评估
Indian J Lepr. 1987 Jan-Mar;59(1):44-9.
7
Clinical analysis of multibacillary leprosy patients after 1-year fixed World Health Organization recommended multidrug therapy at Yangon General Hospital, Myanmar.缅甸仰光总医院接受世界卫生组织推荐的1年固定疗程多药联合化疗后的多菌型麻风病患者的临床分析
J Dermatol. 2008 May;35(5):264-9. doi: 10.1111/j.1346-8138.2008.00464.x.
8
Fixed-duration multidrug therapy in multibacillary leprosy.多菌型麻风的固定疗程多药联合治疗
Int J Lepr Other Mycobact Dis. 1997 Jun;65(2):230-7.
9
Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.在接受氨苯砜单药全疗程治疗后,采用改良多药联合治疗方案对MB型麻风患者进行25年随访。
Lepr Rev. 2009 Jun;80(2):170-6.
10
Relapses in multibacillary leprosy patients after multidrug therapy.多菌型麻风患者在接受多药联合治疗后的复发情况。
Lepr Rev. 2008 Sep;79(3):320-4.

引用本文的文献

1
Clinical profile of leprosy patients: a prospective study.麻风病患者的临床概况:一项前瞻性研究。
Indian J Dermatol. 2014 Mar;59(2):158-62. doi: 10.4103/0019-5154.127676.